Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigation

BACKGROUND: The low data publication rate for Food and Drug Administration (FDA)-approved drugs, and discrepancies between FDA-submitted versus published data, remain a concern. We investigated the publication statuses of sponsor-submitted clinical trials supporting recent anticancer drugs approved...

Descripción completa

Detalles Bibliográficos
Autores principales: Omae, Kenji, Kataoka, Yuki, Tsujimoto, Yasushi, Tsutsumi, Yusuke, Yamamoto, Yosuke, Fukuhara, Shunichi, Furukawa, Toshi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814120/
https://www.ncbi.nlm.nih.gov/pubmed/31651263
http://dx.doi.org/10.1186/s12885-019-6232-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814120/
https://www.ncbi.nlm.nih.gov/pubmed/31651263
http://dx.doi.org/10.1186/s12885-019-6232-x

Ejemplares similares